Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mereo BioPharma
Biotech
Ultragenyx, Mereo's brittle bone drug sustains fracture rate cut
Ultragenyx and Mereo have linked their brittle bone drug to sustained reductions in fracture rates in a midphase clinical trial.
Nick Paul Taylor
Jun 12, 2024 8:55am
Ultragenyx, Mereo's bone disease med cuts fractures by 67%
Oct 16, 2023 12:39pm
Ultragenyx brittle bone drug causes fast improvements in phase 2
Jun 6, 2023 7:42am
Mereo gives in to investor demands, hands over board seats
Oct 28, 2022 10:52am
Activist investor snaps Mereo's olive branch as proxy feud looms
Sep 26, 2022 9:00am
Mereo makes more cuts to extend cash runway into 2025
Sep 1, 2022 9:00am
